ADP-Ribosylation Factor-Like Protein 1 (ARL1) is a GTPase belonging to the ADP-ribosylation factor (ARF) family, which plays a pivotal role in regulating various cellular processes, particularly those related to vesicle trafficking and membrane dynamics. ARL1 is predominantly associated with the Golgi apparatus, a central organelle involved in protein sorting, processing, and trafficking in eukaryotic cells.ARL1's primary function is to regulate the assembly and disassembly of coat protein complexes on Golgi membranes, a critical step in vesicular transport. By cycling between an active, GTP-bound state and an inactive, GDP-bound state, ARL1 controls the recruitment of several effector proteins to the Golgi. These effectors are essential for maintaining Golgi structure, mediating vesicle formation, and directing the trafficking of cargo proteins to their appropriate destinations.
The activity of ARL1 is tightly regulated by specific guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs), ensuring precise control over Golgi function. Dysregulation of ARL1 activity can lead to disruptions in Golgi organization and function, which may have broader implications for cell physiology and pathology.In addition to its role in vesicle trafficking, ARL1 has been implicated in other cellular processes, including lipid metabolism and the maintenance of the cytoskeleton. Its involvement in these diverse functions highlights the importance of ARL1 in cellular homeostasis.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Known to disrupt Golgi structure, it might induce ARL1 expression as a cellular response to maintain Golgi function. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Affects intracellular transport, potentially influencing ARL1 expression in response to altered vesicle trafficking. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Disrupts microtubule dynamics, potentially affecting ARL1 expression due to altered vesicle transport. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, potentially influencing ARL1 expression through cAMP-mediated signaling pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C, which could influence ARL1 expression in signaling pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Involved in cell differentiation, might influence ARL1 expression during developmental processes. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Influences Wnt signaling pathway, potentially affecting ARL1 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, could affect ARL1 expression through pathways involved in cell growth and metabolism. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Affects endosomal acidification, potentially influencing ARL1 expression in response to altered vesicle trafficking. | ||||||